Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03829410
Brief Title: Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a Kras Mutation

First Submitted : February 1, 2019
First Submitted that Met QC Criteria : February 1, 2019
First Posted : February 4, 2019

Last Update Submitted that Met QC Criteria : June 21, 2019
Last Update Posted : June 24, 2019